Filter Results:
(2,525)
Show Results For
- All HBS Web
(5,297)
- People (16)
- News (1,936)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Show Results For
- All HBS Web
(5,297)
- People (16)
- News (1,936)
- Research (2,525)
- Events (3)
- Multimedia (214)
- Faculty Publications (1,884)
Sort by
- November 24, 2020
- Article
4 Strategies to Make Telehealth Work for Elderly Patients
By: Umar Ikram, Susanna Gallani, Jose F. Figueroa and Thomas W. Feeley
As providers have ramped up their use of telehealth during the COVID-19 pandemic, one group—the elderly—has experienced particular challenges in adopting the technologies. This article describes the strategies four innovative provider organizations have used to engage... View Details
Keywords: Telehealth; Health Pandemics; Health Care and Treatment; Internet and the Web; Age; Technology Adoption; Strategy
Ikram, Umar, Susanna Gallani, Jose F. Figueroa, and Thomas W. Feeley. "4 Strategies to Make Telehealth Work for Elderly Patients." Harvard Business Review Digital Articles (November 24, 2020).
- 24 Feb 2009
- First Look
First Look: February 24, 2009
not only experience project-level success with the implementation of new work practices, but also organizational-level success as indicated by overall measures of performance. We tested our hypothesis in a longitudinal study of 23 hospital neonatal intensive View Details
Keywords: Martha Lagace
- 27 Feb 2007
- First Look
First Look: February 27, 2007
the Global Poor: Creating Social and Economic Value. San Francisco: Jossey-Bass, 2007 Abstract In much of the developing world, poor health is a major impediment to both quality of life and economic... View Details
Keywords: Martha Lagace
- January 2023 (Revised September 2024)
- Supplement
The END Fund (B)
By: V. Kasturi Rangan and Courtney Han
Founded in 2012, the END fund focused on eliminating five Neglected Tropical Diseases that accounted for 80% of the tropical diseases affecting nearly 1.5 billion people worldwide. Its roughly $25 million/year annual budget was fully committed when it got news that the... View Details
Keywords: Health Disorders; Investment Funds; Global Range; Nonprofit Organizations; Resource Allocation; Decisions; Health Care and Treatment; Mission and Purpose
Rangan, V. Kasturi, and Courtney Han. "The END Fund (B)." Harvard Business School Supplement 523-064, January 2023. (Revised September 2024.)
- 08 Nov 2024
- Op-Ed
How Private Investors Can Help Solve Africa's Climate Crisis
has quantified the reduction in health care costs from bad outcomes related to automobile pollution. And they have also quantified the time benefit, finding that the BRT so far has reduced a 90-minute trip... View Details
- March 1990 (Revised March 1992)
- Case
New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign
By: V. Kasturi Rangan and Sohel Karim
Describes the background leading to the development of an advertising campaign to help prevention of AIDS in New York City. The three television networks, however, for various reasons reject the campaign, to the dismay of Saatchi & Saatchi executives. View Details
Keywords: Advertising Campaigns; Growth and Development; Health Care and Treatment; Marketing Communications; Failure; Advertising Industry; New York (city, NY)
Rangan, V. Kasturi, and Sohel Karim. "New York Against AIDS (A): The Saatchi & Saatchi Compton Advertising Campaign." Harvard Business School Case 590-036, March 1990. (Revised March 1992.)
- 26 Apr 2016
- First Look
April 26
do. Purchase this case: https://cb.hbsp.harvard.edu/cbmp/product/316042-PDF-ENG Harvard Business School Case 315-006 La Ribera Health Department La Ribera was a privately managed, publicly funded health... View Details
Keywords: Sean Silverthorne
- 24 Mar 2022
- Research & Ideas
Why Cutting Jobless Aid Isn't the Answer to Worker Shortages
16,000 people unemployed at the end of April 2021 who received federal benefits through the CARES Act of 2020. The authors analyzed anonymized bank transaction data from January 1 through September 17, 2021. Researchers then compared the... View Details
Keywords: by Rachel Layne
- 2018
- Chapter
The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century
By: Nicholas Bagley, Benjamin Berger, Amitabh Chandra, Craig Garthwaite and Ariel Dora Stern
On the 35th anniversary of the adoption of the Orphan Drug Act (ODA), we describe the enormous changes in the markets for therapies for rare diseases that have emerged over recent decades. The most prominent example is the fact that the profit-maximizing price of new... View Details
Keywords: Health Care and Treatment; Laws and Statutes; Research and Development; Investment; Markets; Monopoly
Bagley, Nicholas, Benjamin Berger, Amitabh Chandra, Craig Garthwaite, and Ariel Dora Stern. "The Orphan Drug Act at 35: Observations and an Outlook for the Twenty-First Century." Chap. 4 in Innovation Policy and the Economy, Volume 19, edited by Josh Lerner and Scott Stern, 97–137. University of Chicago Press, 2018.
- February 2009
- Teaching Note
Examining the Adoption of Drug-Eluting Stents (TN)
By: Elie Ofek and Peter Wickersham
Teaching Note for [509028]. View Details
- 31 May 2017
- Sharpening Your Skills
10 Harvard Business School Research Stories That Will Make Your Mouth Water
quality with affordable prices. Gary Pisano and Oldani explain how. A Bank That Takes Parmesan Cheese as Collateral: The Cheese Stands a Loan Nikolaos Trichakis discusses the Italian regional bank Credito Emiliano, which accepts young... View Details
- 2012
- Working Paper
The Need for (long) Chains in Kidney Exchange
By: Itai Ashlagi, David Gamarnik, Michael A. Rees and Alvin E. Roth
It has been previously shown that for sufficiently large pools of patient-donor pairs, (almost) efficient kidney exchange can be achieved by using at most 3-way cycles, i.e., by using cycles among no more than 3 patient-donor pairs. However, as kidney exchange has... View Details
Keywords: Networks; Complexity; Performance Efficiency; Medical Specialties; Health Care and Treatment; Philanthropy and Charitable Giving
Ashlagi, Itai, David Gamarnik, Michael A. Rees, and Alvin E. Roth. "The Need for (long) Chains in Kidney Exchange." NBER Working Paper Series, No. 18202, July 2012.
- March – April 2010
- Article
Healthcare Reform and Its Implications for the U.S. Economy
Keywords: Health Care and Treatment; Governing Rules, Regulations, and Reforms; Economy; United States
Herzlinger, Regina E. "Healthcare Reform and Its Implications for the U.S. Economy." Business Horizons 53, no. 2 (March–April 2010).
- January 2022 (Revised August 2022)
- Case
Hello Heart: The Next Generation of Chronic Disease Management Apps
By: Ariel D. Stern and Danielle Golan
Hello Heart, a hypertension management app debated whether to go deep and cover other heart conditions, or to expand its solution to other chronic conditions. View Details
Keywords: Health; Health Care and Treatment; Information Technology; Mobile and Wireless Technology; Analysis; Business Startups; Transition; Customer Focus and Relationships; Customer Satisfaction; Decision Making; Demographics; Design; Entrepreneurship; Venture Capital; Technological Innovation; Growth and Development Strategy; Product Launch; Product Design; Product Development; Business Strategy; Competitive Strategy; Competitive Advantage; Customization and Personalization; Business Growth and Maturation; Business Model; Strategy; Applications and Software; Health Industry; Health Industry; Israel; United States
Stern, Ariel D., and Danielle Golan. "Hello Heart: The Next Generation of Chronic Disease Management Apps." Harvard Business School Case 622-061, January 2022. (Revised August 2022.)
- 2024
- Working Paper
Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances
By: Amar Bhidé and Srikant M. Datar
In 2017, the US Food and Drug Administration (FDA) approved an immunotherapeutic treatment, called CAR-T therapy, for two kinds of blood cancers—acute leukemia (ALL) and a lymphoma. We describe 1) how CAR-T works, 2) the foundational advances and discoveries, 3) the... View Details
Keywords: Immunotherapy; Health Care and Treatment; Innovation and Invention; Research and Development; Governing Rules, Regulations, and Reforms
Bhidé, Amar, and Srikant M. Datar. "Chimeric Antigen Receptor T-Cell Therapy—Living Drugs: Case Histories of Transformational Advances." Harvard Business School Working Paper, No. 21-035, August 2020. (Revised May 2024.)
- January 2018
- Case
Spark Therapeutics: Pioneering Gene Therapy
By: Robert F. Higgins and Tina Liu
Spark Therapeutics is a pioneering gene therapy startup. It was spun out of The Children’s Hospital of Philadelphia (CHOP). The company had taken with it much of the intellectual property and talent that CHOP had developed. The company is considering an initial public... View Details
Keywords: Health Care and Treatment; Innovation and Invention; Business Startups; Opportunities; Problems and Challenges; Strategy
Higgins, Robert F., and Tina Liu. "Spark Therapeutics: Pioneering Gene Therapy." Harvard Business School Case 818-059, January 2018.
- April 2017
- Supplement
Imprimis (C)
By: Ramon Casadesus-Masanell, Karen Elterman and Marc Appel
This case is a supplement to Imprimis (A & B). Set in 2015, it first describes Imprimis’s decision to introduce its own line of compounded eye drop medication called LessDrops. The case then examines the moral dilemma faced by CEO Mark Baum, who was struck by the... View Details
Keywords: Health Care and Treatment; Cost; Moral Sensibility; Competitive Strategy; Decision Choices and Conditions; Pharmaceutical Industry; United States
Casadesus-Masanell, Ramon, Karen Elterman, and Marc Appel. "Imprimis (C)." Harvard Business School Supplement 717-497, April 2017.
- November 2020
- Supplement
Improving Access at VA (Update)
By: Ryan W. Buell
In November 2020, Chief Veterans Experience Officer, Lynda Davis, and Deputy Chief Veterans Experience Officer, Barbara C. Morton reflect on a busy four years leading the Veterans Experience Office at the U.S. Department of Veterans Affairs. The case provides an update... View Details
Keywords: Government; Service Management; Leading Change; Transformation; Service Operations; Management; Health Care and Treatment; Government Administration; Performance Improvement; Public Administration Industry; United States
Buell, Ryan W. "Improving Access at VA (Update)." Harvard Business School Supplement 621-070, November 2020.
- January 2014 (Revised June 2014)
- Supplement
23andMe: Genetic Testing for Consumers (B)
By: John A. Quelch and Margaret L. Rodriguez
Following the FDA's letter in November 2013, which ordered 23andMe to cease sales of its DNA test kits, observers wondered how co-founder and CEO, Anne Wojcicki, would guide the company in the presence of uncertainty. View Details
Keywords: Risk and Uncertainty; Genetics; Crisis Management; Health Care and Treatment; Product Development; Business and Government Relations; Biotechnology Industry; Consumer Products Industry; United States
Quelch, John A., and Margaret L. Rodriguez. "23andMe: Genetic Testing for Consumers (B)." Harvard Business School Supplement 514-095, January 2014. (Revised June 2014.)
- 18 Sep 2007
- First Look
First Look: September 18, 2007
"dashboard," and the Performance Manager. Provides students with an opportunity to identify key design principles for health care information systems, and to discuss the unique implementation... View Details
Keywords: Martha Lagace